Coenzyme Q10

What is coenzyme Q10?

Coenzyme Q10, or CoQ10, occurs naturally in the human body, with high concentrations in organs including the heart, liver and kidneys. A substance’s natural presence does not mean everyone needs additional intake. [1]

Research addresses specific situations, including additional treatment in heart failure, muscle symptoms during statin therapy and physical performance. These populations cannot be merged into a general promise about energy or healthy ageing.

Ubiquinone and ubiquinol

Ubiquinone is the oxidised form and ubiquinol the reduced form. A small comparison in twelve healthy people found higher blood levels with ubiquinol after four weeks at 200 mg daily for each form. It tested particular formulations in a fixed sequence. [8]

The study measured availability, not fewer illnesses or better quality of life. It therefore cannot establish general clinical superiority of every ubiquinol preparation over every ubiquinone preparation. [8]

Product comparisons need the form, actual Q10 quantity per daily serving, additional ingredients and the preparation studied. A formulation with greater absorption still requires research addressing the desired outcome. More in the bloodstream is one measurement; a meaningful benefit is another.

Mechanisms, blood measurements and symptoms

A plausible mechanism is a starting point for research. A suitable comparison is needed to establish whether an intervention improves a relevant outcome in a particular population. Change within a treated group is insufficient: symptoms may also change with placebo, accompanying treatment or time.

Independence of evidence matters too. A meta-analysis containing an already described trial does not constitute a second independent confirmation of that trial. The following cards therefore show both individual findings and the breadth of the evidence being pooled.

How much should someone take?

Coenzyme Q10 has no established EFSA daily nutritional requirement comparable to vitamins or minerals. EFSA’s assessment of proposed general claims on energy metabolism, blood pressure, oxidative protection and other functions did not establish the claimed cause-and-effect relationships. It does not authorise those general promises. [2]

Amounts used in trials address individual research questions. They are neither a daily requirement nor a universal safe upper limit. Turning the highest studied amount into a personal long-term dose would be methodologically unsound.

Heart failure and muscle symptoms

Physical performance: the 2026 evidence

Who needs professional guidance?

CoQ10 can interact with warfarin and insulin and may be unsuitable alongside certain cancer treatments. Digestive symptoms and sleep problems can occur. [1]

New muscle symptoms while taking statins should be discussed with the prescribing clinician. The studies presented here do not justify independently stopping a statin or changing its dose. Individual treatment planning remains central in heart failure.

A brief record can help that discussion: when symptoms began, when medication started or changed, the exact Q10 product being used and the outcome being sought. Agreeing a reassessment point helps prevent an unhelpful trial from becoming indefinite use without a clear reason.

These human studies do not determine doses for dogs, cats or plants. This profile therefore provides no animal or cultivation instructions derived from human quantities.